Aesthetic Management Partners

CompanyUnited States

Aesthetic Management Partners develops one asset, approved (Cellenis Exo-ME in skin aging). Mostly cell therapy; based in the United States.

1
Asset
Furthest stage
Approved
0
Trials
0
Signals

Pipeline

1
  • Cellenis Exo-ME

    Autologous extracellular vesicle skin booster technology to improve skin quality

    Approved, Cell therapy, skin aging, skin quality

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies6

Intelligence